Genelux Market Cap

Genelux has a market cap or net worth of $91.34 million as of April 26, 2024. Its market cap has decreased by -86.78% in one year.

Market Cap

91.34M

Enterprise Value

70.02M

1-Year Change

-86.78%

Ranking

#4196

Market Cap Chart

Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $91.34M, a decrease of -35.53%. That is a compound annual growth rate of -29.69%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	88.70M	-3.80%
Apr 24, 2024	92.20M	-0.86%
Apr 23, 2024	93.00M	3.91%
Apr 22, 2024	89.50M	-18.86%
Apr 19, 2024	110.30M	6.98%
Apr 18, 2024	103.10M	6.73%
Apr 17, 2024	96.60M	2.77%
Apr 16, 2024	94.00M	-7.39%
Apr 15, 2024	101.50M	-7.81%
Apr 12, 2024	110.10M	-3.76%
Apr 11, 2024	114.40M	-1.55%
Apr 10, 2024	116.20M	-5.45%
Apr 9, 2024	122.90M	-1.52%
Apr 8, 2024	124.80M	-5.24%
Apr 5, 2024	131.70M	4.19%
Apr 4, 2024	126.40M	-2.62%
Apr 3, 2024	129.80M	-7.48%
Apr 2, 2024	140.30M	0.21%
Apr 1, 2024	140.00M	-18.51%
Mar 28, 2024	171.80M	6.84%
Mar 27, 2024	160.80M	1.13%
Mar 26, 2024	159.00M	-3.05%
Mar 25, 2024	164.00M	-1.32%
Mar 22, 2024	166.20M	2.15%
Mar 21, 2024	162.70M	-1.75%

View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Elicio Therapeutics	93.01M
Elutia	92.79M
Armata Pharmaceuticals	91.48M
AlloVir	91.25M
ProPhase Labs	89.32M
Allakos	88.75M
BeyondSpring	88.57M
Allurion Technologies	88.53M

Market Cap Rankings